Literature DB >> 4682084

Chemotherapy of mouse myeloma: quantitative cell cultures predictive of response in vivo.

M Ogawa, D E Bergsagel, E A McCulloch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4682084

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

1.  In vitro myelosuppression and immunosuppression by ethanol.

Authors:  G Tisman; V Herbert
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

2.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

Review 3.  Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development.

Authors:  D D von Hoff
Journal:  Cancer Metastasis Rev       Date:  1988-12       Impact factor: 9.264

Review 4.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

5.  Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth.

Authors:  F R Ahmann; H S Garewal; R Schifman; A Celniker; S Rodney
Journal:  In Vitro Cell Dev Biol       Date:  1987-07

6.  Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).

Authors:  D J Straus; J Myers; B Koziner; B J Lee; B D Clarkson
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 7.  Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients.

Authors:  P J Selby; D Raghavan
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

Review 8.  [Predictive tumor tests in chemotherapeutic treatment concepts of malignant diseases].

Authors:  K Possinger; H Ehrhart
Journal:  Klin Wochenschr       Date:  1983-01-17

9.  Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment.

Authors:  R I Freshney; J Paul; I M Kane
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

10.  The sensitivity of cells in exponential and stationary phases of growth to bleomycin and to 1,3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1973-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.